About Us

Committed to creating life changing therapies with the highest quality that are affordable to all Sri Lankans

Our Promise

Our Purpose

“Make Premium Healthcare Affordable” because all Sri Lankan families deserve equal access to high quality medicines.

Our Vision

“Our Vision is for Morison to be the most trusted pharma brand in Sri Lanka by offering world-class quality, global manufacturing excellence and the latest therapies to Sri Lankan families at affordable prices, while upholding the highest levels of integrity. We will do this alongside driving growth in adjacent healthcare verticals and international markets.”

Our New Journey

With the launch of our new state-of-the-art research and manufacturing facility in Homagama, we aspire to embark on a new journey.

We are working towards creating a strong pharmaceutical brand with a patient centric medicine portfolio while driving the local pharmaceutical industry to the next level.

We commit towards continuously complying to premium quality standards, investing in the latest technology, absorbing the right talent and bringing in novel molecules advancing in the global pharmaceutical arena.

We marked the launch of our commercial operations from our new manufacturing facility on 26th May 2022, after obtaining the seal of approval from the National Medicines Regulatory Authority (NMRA).

As our 1st batches we manufactured and released Chlorphenamine Oral Solution and Paracetamol 500mg tablets, at a time they are most needed by the nation.

We are hopeful that we can make a step change in the pharma manufacturing industry in Sri Lanka by staying true to our purpose of “Making Premium Healthcare Affordable”


Our History

1939 – J. L. Morison Son & Jones (Ceylon) was incorporated as a trading post of J. L. Morison Son & Jones (UK)

1959 – Ventured into pharmaceutical manufacturing with the inauguration of MSJ Industries (Ceylon) Ltd, our first manufacturing facility at Mutwal Aluthmawatha, becoming one of the pioneers of generic pharmaceutical manufacturing in Sri Lanka

2013 – The diversified conglomerate Hemas Holdings PLC acquired the majority shareholding of the company, making Morison a subsidiary of the Hemas Group

2017 – The corporate brand name of J.L. Morison Son & Jones (Ceylon) PLC was re-branded as Morison PLC, with a logo that is simple and contemporary

2020 – Morison unveiled Sri Lanka’s first and largest oral solid and liquid dosage pharmaceutical manufacturing facility that complies with WHO GMP and EU GMP quality standards, in Pitipana Homagama

2021 – Morison PLC became a limited liability company with Hemas Holdings owning more than 90% of its shareholding, and is now known as Morison Ltd

2021 – Introduced “EmpaMor” (Empagliflozin 10mg  25mg), the first ever locally manufactured SGLT2 (Sodium-Glucose Co-Transported-2), an oral medication to treat Type-2 Diabetes, at a significant price benefit from competition.

2022 – Launched commercial operations from our new state-of-the-art manufacturing facility in Homagama on 26th May 2022

Board of Directors

Driven by experience and expertise, our leadership team inspires us to surpass our goals and deliver stakeholder value.